HomeCompareBAMPX vs JNJ

BAMPX vs JNJ: Dividend Comparison 2026

BAMPX yields 5.48% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BAMPX wins by $8.7K in total portfolio value
10 years
BAMPX
BAMPX
● Live price
5.48%
Share price
$13.35
Annual div
$0.73
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.7K
Annual income
$777.39
Full BAMPX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BAMPX vs JNJ

📍 BAMPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAMPXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAMPX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAMPX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAMPX
Annual income on $10K today (after 15% tax)
$465.70/yr
After 10yr DRIP, annual income (after tax)
$660.78/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $42.83/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAMPX + JNJ for your $10,000?

BAMPX: 50%JNJ: 50%
100% JNJ50/50100% BAMPX
Portfolio after 10yr
$24.4K
Annual income
$802.58/yr
Blended yield
3.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BAMPX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAMPX buys
0
JNJ buys
0
No recent congressional trades found for BAMPX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAMPXJNJ
Forward yield5.48%3.36%
Annual dividend / share$0.73$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$28.7K$20.0K
Annual income after 10y$777.39$827.78
Total dividends collected$6.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BAMPX vs JNJ ($10,000, DRIP)

YearBAMPX PortfolioBAMPX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,248$547.89$10,676$355.77+$572.00BAMPX
2$12,611$575.94$11,407$389.39+$1.2KBAMPX
3$14,097$603.50$12,198$426.53+$1.9KBAMPX
4$15,715$630.49$13,056$467.62+$2.7KBAMPX
5$17,472$656.85$13,987$513.12+$3.5KBAMPX
6$19,377$682.51$14,998$563.56+$4.4KBAMPX
7$21,441$707.42$16,098$619.52+$5.3KBAMPX
8$23,673$731.56$17,295$681.69+$6.4KBAMPX
9$26,085$754.89$18,599$750.82+$7.5KBAMPX
10$28,689$777.39$20,022$827.78+$8.7KBAMPX

BAMPX vs JNJ: Complete Analysis 2026

BAMPXStock

The investment seeks a balance between long term capital appreciation and high current income, with an emphasis on income. The fund, which is a fund of funds, normally obtains exposure to equity securities in an amount equal to 40% of its assets and exposure to fixed-income securities in an amount equal to 60% of its assets. Normally, the advisor intends to invest primarily in affiliated open-end funds and affiliated ETFs. The fund may, when consistent with its investment objective, buy or sell options or futures, or enter into total return swaps and foreign currency transactions (collectively, commonly known as derivatives).

Full BAMPX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BAMPX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAMPX vs SCHDBAMPX vs JEPIBAMPX vs OBAMPX vs KOBAMPX vs MAINBAMPX vs ABBVBAMPX vs MRKBAMPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.